Optimising medications for patients with cancer and multimorbidity: The case for deprescribing

Turner, Justin P., Kantilal, Kumud, Kantilal, Kavita, Holmes, Holly M. and Koczwara, Bogda (2020) Optimising medications for patients with cancer and multimorbidity: The case for deprescribing. Clinical Oncology, 32 (9). pp. 609-617. ISSN 0936-6555

Full text not available from this repository.


The majority of patients diagnosed with cancer are aged over 65 years and have two or more chronic conditions in addition to cancer and the risk of chronic conditions increases further after cancer. The presence of multimorbidity adds complexity to care, as patients' goals of care and the focus of treatment can change with a diagnosis of cancer. Multimorbidity is frequently associated with polypharmacy, the use of potentially inappropriate medications, the presence of adverse drug reactions and potential drug–drug interactions: all of which impact on health outcomes and the cost of care. Consequently, it is vital that a systematic approach is taken to regularly review cancer patients' medication regimens to ensure that they support an optimal balance of benefits with acceptable levels of harm. Several patient and clinician resources are presented to guide the process of medication review and deprescribing.

Item Type: Article
Uncontrolled Keywords: clinical oncology,deprescribing,multimorbidity and cancer,polypharmacy,potentially inappropriate medications,oncology,radiology nuclear medicine and imaging,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2730
Faculty \ School: Faculty of Science > School of Pharmacy
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 30 Jun 2020 23:59
Last Modified: 20 Apr 2023 17:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/75838
DOI: 10.1016/j.clon.2020.05.015

Actions (login required)

View Item View Item